San Francisco based Vir Biotechnology is evaluating if previously identified monoclonal antibodies ( mAbs ) are affective against the virus.
The previously identified monoclonal antibodies are being tested in Vir Biotechnology , San Francisco , to determine their effectiveness against coronavirus .